HDFC Pharma And Healthcare Fund
- NAV as on 25 Sep 2026
- ₹21.83-0.41%1 day
- Return since launch
- 30.1%
- 52-week range
- ₹16.36 — ₹22.10
- AUM
- ₹3,311 Cr
HDFC Pharma And Healthcare Fund is a Sectoral-Pharma equity fund from HDFC Mutual Fund with ₹3,311 Cr under management, launched in 2023. The expense ratio is 2.16% and the SEBI riskometer reading is Very High.
Performance
HDFC Pharma And Healthcare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +30.3% against +19.5% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 38.7% | +17.9 pts | 20.9% | 26.4% |
| 2Y | 25.0% | +8.2 pts | 16.8% | 15.2% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 0.9% | +0.7 pts | 0.2% | -0.3% |
| 3M | 7.8% | +1.6 pts | 6.2% | 6.0% |
| 6M | 27.0% | +4.8 pts | 22.1% | 20.9% |
| 1Y | 30.3% | +9.5 pts | 20.9% | 19.5% |
| 2Y | 16.7% | +8.5 pts | 8.2% | 6.5% |
Since launch (14 Sep 2023): 30.1%
Calendar-year returns
Category averageShow as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | 1.2% | +3.3 pts | -2.0% |
| 2024 | 49.8% | +8.9 pts | 40.9% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.11%
Expense ratio as on 24 Sep 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.65%
- Brokerage
- 0.04%
- Transaction charges
- 0.01%
- Statutory levies
- 0.41%
- Exit load
- Exit load of 1%, if redeemed within 30 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
Portfolio
HDFC Pharma And Healthcare Fund portfolio
Portfolio as of 31 Aug 2026
Asset allocation
- Equity98.4%
- Other1.6%
Market cap split
- Large28.7%
- Mid34.1%
- Small37.2%
- P/E
- 50.42
- P/B
- 6.64
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Divi's Laboratories Ltd. | Healthcare | 9.54% | ₹316 Cr | +8.02% | +8.38% | +8.30% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 8.94% | ₹296 Cr | +9.20% | +9.81% | +10.39% |
| Torrent Pharmaceuticals Ltd. | Healthcare | 4.08% | ₹135 Cr | — | +2.34% | +3.74% |
| Max Healthcare Institute Ltd. | Healthcare | 4.06% | ₹134 Cr | +5.26% | +6.36% | +3.26% |
| Lupin Ltd. | Healthcare | 4.04% | ₹134 Cr | +5.45% | +6.44% | +6.73% |
| Cipla Ltd. | Healthcare | 3.94% | ₹130 Cr | +4.92% | — | +6.56% |
| Aster DM Quality Care Ltd. | Healthcare | 3.84% | ₹127 Cr | +5.18% | +5.42% | +3.38% |
| Neuland Laboratories Ltd. | Healthcare | 3.70% | ₹122 Cr | +2.98% | — | — |
| Anthem Biosciences Ltd. | Healthcare | 3.48% | ₹115 Cr | +4.15% | +4.46% | +3.47% |
| Acutaas Chemicals Ltd. | Healthcare | 3.24% | ₹107 Cr | +4.50% | +3.60% | +2.44% |
| Ipca Laboratories Ltd. | Healthcare | 3.23% | ₹107 Cr | +3.50% | +4.80% | +4.62% |
| Shilpa Medicare Ltd. | Healthcare | 3.10% | ₹103 Cr | +2.28% | +1.68% | — |
| Alkem Laboratories Ltd. | Healthcare | 3.06% | ₹101 Cr | +4.36% | +6.21% | +3.94% |
| Global Health Ltd. | Healthcare | 2.85% | ₹94.38 Cr | +3.08% | +1.84% | — |
| Rubicon Research Ltd. | Healthcare | 2.82% | ₹93.29 Cr | +1.35% | +1.22% | — |
| Fortis Healthcare Ltd. | Healthcare | 2.37% | ₹78.62 Cr | +3.41% | +4.02% | +1.87% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 2.34% | ₹77.60 Cr | +3.28% | +6.62% | +6.78% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 2.25% | ₹74.39 Cr | +3.16% | +3.61% | +3.73% |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 2.24% | ₹74.11 Cr | +2.70% | +2.30% | +2.45% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 1.94% | ₹64.29 Cr | — | — | — |
| Zydus Lifesciences Ltd. | Healthcare | 1.93% | ₹63.74 Cr | +2.50% | — | — |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 1.90% | ₹62.91 Cr | — | — | — |
| Metropolis Healthcare Ltd. | Healthcare | 1.90% | ₹62.98 Cr | +2.54% | +2.53% | +2.82% |
| company:20769 | Healthcare | 1.77% | ₹58.44 Cr | — | — | — |
| Biocon Ltd. | Healthcare | 1.73% | ₹57.29 Cr | +1.33% | — | — |
| Wockhardt Ltd. | Healthcare | 1.61% | ₹53.36 Cr | +2.44% | +1.73% | +1.93% |
| Sai Life Sciences Ltd. | Healthcare | 1.60% | ₹52.83 Cr | +1.78% | +2.09% | +1.59% |
| Others | Others | 1.58% | ₹52.37 Cr | -0.34% | -0.20% | +0.16% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 1.39% | ₹46.01 Cr | — | — | — |
| Thyrocare Technologies Ltd. | Healthcare | 1.31% | ₹43.47 Cr | +1.54% | +1.39% | — |
| company:20823 | Healthcare | 1.21% | ₹40.00 Cr | — | — | — |
| Ajanta Pharma Ltd. | Healthcare | 1.18% | ₹38.97 Cr | — | — | — |
| Gland Pharma Ltd. | Healthcare | 1.09% | ₹36.13 Cr | +1.19% | +1.12% | +2.28% |
| CORONA Remedies Ltd. | Healthcare | 1.07% | ₹35.54 Cr | — | +0.55% | — |
| Eris Lifesciences Ltd. | Healthcare | 1.06% | ₹35.19 Cr | +1.61% | +2.28% | +3.60% |
| Jubilant Pharmova Ltd. | Healthcare | 0.85% | ₹28.01 Cr | +1.34% | +1.35% | +1.70% |
| Bajaj Healthcare Ltd. | Healthcare | 0.57% | ₹18.98 Cr | +0.73% | +0.92% | +1.16% |
| Novartis India Ltd. | Healthcare | 0.47% | ₹15.64 Cr | +0.64% | — | — |
| Laxmi Dental Ltd. | Healthcare | 0.38% | ₹12.60 Cr | +0.63% | +0.61% | +1.15% |
| Cohance Lifesciences Ltd. | Healthcare | 0.34% | ₹11.40 Cr | +0.46% | — | +1.98% |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Others | -2.62% | -0.25% | +2.37% |
| Torrent Pharmaceuticals Ltd. | 2.28% | 4.08% | +1.80% |
| company:20769 | 0.00% | 1.77% | +1.77% |
| company:20823 | 0.00% | 1.21% | +1.21% |
| Rubicon Research Ltd. | 1.61% | 2.82% | +1.21% |
| Aster DM Quality Care Ltd. | 4.70% | 3.84% | -0.86% |
| Shilpa Medicare Ltd. | 2.25% | 3.10% | +0.85% |
| Max Healthcare Institute Ltd. | 4.82% | 4.06% | -0.76% |
| Sun Pharmaceutical Industries Ltd. | 9.66% | 8.94% | -0.72% |
| Cipla Ltd. | 4.64% | 3.94% | -0.70% |
| Lupin Ltd. | 4.67% | 4.04% | -0.63% |
| Alkem Laboratories Ltd. | 3.67% | 3.06% | -0.61% |
| Jupiter Life Line Hospitals Ltd. | 2.45% | 1.94% | -0.51% |
| Krishna Institute of Medical Sciences Ltd | 2.70% | 2.25% | -0.45% |
| Fortis Healthcare Ltd. | 2.79% | 2.37% | -0.42% |
| Divi's Laboratories Ltd. | 9.14% | 9.54% | +0.40% |
| Acutaas Chemicals Ltd. | 3.58% | 3.24% | -0.34% |
| Neuland Laboratories Ltd. | 3.40% | 3.70% | +0.30% |
| Biocon Ltd. | 2.01% | 1.73% | -0.28% |
| Wockhardt Ltd. | 1.89% | 1.61% | -0.28% |
| Glenmark Pharmaceuticals Ltd. | 2.59% | 2.34% | -0.25% |
| Metropolis Healthcare Ltd. | 2.14% | 1.90% | -0.24% |
| Global Health Ltd. | 3.05% | 2.85% | -0.20% |
| Apollo Hospitals Enterprise Ltd. | 1.58% | 1.39% | -0.19% |
| Eris Lifesciences Ltd. | 1.25% | 1.06% | -0.19% |
| Zydus Lifesciences Ltd. | 2.10% | 1.93% | -0.17% |
| CORONA Remedies Ltd. | 1.24% | 1.07% | -0.17% |
| Jubilant Pharmova Ltd. | 1.01% | 0.85% | -0.16% |
| Thyrocare Technologies Ltd. | 1.42% | 1.31% | -0.11% |
| Ajanta Pharma Ltd. | 1.28% | 1.18% | -0.10% |
| Laxmi Dental Ltd. | 0.47% | 0.38% | -0.09% |
| Anthem Biosciences Ltd. | 3.56% | 3.48% | -0.08% |
| Bajaj Healthcare Ltd. | 0.65% | 0.57% | -0.08% |
| Novartis India Ltd. | 0.51% | 0.47% | -0.04% |
| Dr. Reddy's Laboratories Ltd. | 1.92% | 1.90% | -0.02% |
| Gland Pharma Ltd. | 1.07% | 1.09% | +0.02% |
| Sai Life Sciences Ltd. | 1.62% | 1.60% | -0.02% |
| Cohance Lifesciences Ltd. | 0.36% | 0.34% | -0.02% |
| Vijaya Diagnostic Centre Ltd. | 2.23% | 2.24% | +0.01% |
| Ipca Laboratories Ltd. | 3.22% | 3.23% | +0.01% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹3,579 Cr | 2.19% | 27.3% | 17.7% | 20.1% |
 ICICI Prudential Healthcare Fund | ₹6,996 Cr | 2.07% | 14.5% | 14.2% | 19.4% |
 SBI Healthcare Opportunities Fund | ₹5,796 Cr | 1.99% | 33.1% | 19.9% | 22.2% |
 Mirae Asset Healthcare Fund | ₹3,555 Cr | 2.03% | 29.9% | 18.4% | 19.7% |
 UTI Healthcare Fund | ₹1,444 Cr | 2.21% | 30.4% | 19.1% | 21.1% |
 LIC MF Healthcare Fund | ₹103 Cr | 2.67% | 28.7% | 16.9% | 17.9% |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
Fund managers
- Nikhil MathurMr. Mathur has done B.Tech and PGDM in FinancePrior to joining HDFC Mutual Fund, he has worked with Ambit Capital, Goldman Sachs, Deloitte India and EY
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months26.96% absolute | ₹60,000 | ₹76,176 | 26.96% | |
| 1 year30.34% annualised | ₹1,20,000 | ₹1,41,670 | 18.06% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.